13. 重要合同

14. 重要合同与协议 Key Contracts & Agreements

14.1 [Celzy香港]与[上海泉生公司]的共同研发合同及其相关背景介绍和关联文件 [Celzyva Hong Kong]–[Shanghai Quansheng Company] Co-development Agreement, Relevant Background Information, and Related Documents

01. 情况简介【aCGT Hong Kong】与【上海泉生公司】合作研发 Co-development by [aCGT Hong Kong] and [Shanghai Quansheng Company].pdf

02. Co-development Agreement_aCGT-HK & Shanghai Quansheng Company

03. 在研新药成果资料和技术转移不涉及人类遗传资源管理审批Non-Involvement of HGR Management Approval for the Data and Technology Transfer of IND.pdf

04. 中国细胞与基因药物跨境技术转移案例汇总Summary of Cross-Border Technology Transfer Cases for Cellular and Genetic Drugs in China.pdf

05. 在中国按照ICH完成的新药研发数据可同时向中国药监局美国FDA欧盟EMA申报 ICH-compliant data from China can be submitted simultaneously to NMPA, FDA, and EMA.pdf

14.2 [Celzyva香港]独家授权[Celzyva美国加州]中国内地外全球申报、生产、临床试验和市场营销 [Celzyva Hong Kong] Grants [Celzyva USA (California)] Exclusive Rights for Global Regulatory Filings, Manufacturing, Clinical Trials, and Commercialization Outside Mainland China

“Co-Development Agreement” & “Lisencing Agreement”.pdf

1. [Celzyva HK]-[Celzyva California] License Agreement.pdf

2. aCGT USA as the Principal Global Operating and Commercialization Entity Holding Substantially All Value.pdf

14.3 Celzyva合作方三亿元人民币融资合同 RMB 300 Million Financing Agreement of Celzyva’s Collaboration PartnerRMB

............